ITEOS THERAPEUTICS
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 23, 2018 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 58 Total Citation Count
- Nov 08, 2013 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9873690 3-indol substituted derivatives, pharmaceutical compositions and methods for useMar 17, 16Jan 23, 18[A61K, C07D]
9758505 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for useFeb 11, 15Sep 12, 17[A61K, C07D]
9603836 Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitorsMay 14, 15Mar 28, 17[A61K, C07D]
9126984 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for useNov 08, 13Sep 08, 15[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0263,087 NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USEAbandonedNov 07, 14Sep 15, 16[A61K]
2015/0328,228 NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USEAbandonedJul 24, 15Nov 19, 15[A61K]
2015/0266,857 NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USEAbandonedMar 17, 15Sep 24, 15[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.